JHS Svendgaard board to meet on May 26 for FY26 results
JHS Svendgaard Laboratories Limited will hold a board meeting on May 26, 2026, to approve audited financial results for the year ended March 31, 2026. The trading window is closed from April 1 until 48 hours post-results announcement.
*this image is generated using AI for illustrative purposes only.
JHS Svendgaard Laboratories Limited has announced that its board of directors will meet on Tuesday, May 26, 2026. The primary agenda for the meeting is to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The board will review both standalone and consolidated financial statements along with the audit reports from the statutory auditors.
In compliance with the SEBI (Prohibition of Insider Trading) Regulations, the company has closed its trading window for designated persons effective April 1, 2026. This window will remain closed until 48 hours after the announcement of the audited financial results. This measure is intended to prevent insider trading during the period leading up to the disclosure of price-sensitive information.
Key Meeting Details
| Detail | Information |
|---|---|
| Meeting Date | May 26, 2026 |
| Purpose | Audited Financial Results for FY26 |
| Financial Year End | March 31, 2026 |
| Results Type | Standalone and Consolidated |
The intimation regarding the board meeting was sent to the Bombay Stock Exchange and the National Stock Exchange of India. The company has stated that the formal notice and relevant information will be available on its official website. The meeting is being held pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for JHS Svendgaard Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.51% | +0.82% | -5.82% | -20.41% | -38.45% | -59.57% |
How might JHS Svendgaard's FY26 revenue and profit margins compare to the previous fiscal year, given the competitive dynamics in the personal care and oral hygiene contract manufacturing sector?
Will the board consider announcing a dividend or any capital allocation strategy alongside the FY26 results, and how could this impact investor sentiment?
Are there any potential expansion plans, new client acquisitions, or capacity additions that JHS Svendgaard might disclose following the approval of FY26 financial results?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
